TOTAL VOLUME:

$166.8b

24H VOL:

$89,987,006

24H TRANSACTIONS:

3,258,908,236

OPEN INTEREST:

$1,696,807,265

332,071

Markets across

35,607

events

MATCHED EVENTS:

3,434

PLATFORM COVERAGE:

5

Polymarket:

36%

VS.

Kalshi:

64%

BETA
Dashboards
Tour
All
Measles cases in U.S. by November 30?
Health
polymarket

Measles cases in U.S. by November 30?

Oct 30, 2026, 11:33 AM ET - Nov 30, 2026, 11:59 PM ET
Total volume:
$10,621
Volume 24h:
$2,010--
Liquidity:
$2,264
50%
Open interest:
$1,524--

6000+

 - Polymarket

6000+ - Polymarket

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolves Nov 30, 2026

Time left: 08d:16h:12m

Will there be at least 6000 measles cases in the U.S. by November 30, 2026?

91%chance
Amount

$

Trade on
polymarket

Trade on Polymarket

At 94¢ buys you 106 shares | Odds: 91% Total Payout: $106 | Net Profit: $6 Multiplier: 1.06x | ROI: 6% High Projected APY: 1,128% 8 days to resolution
You will be redirected to the platform to complete this trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h Vol Δ
7d Vol Δ
Open Interest
Ends in
Result
polymarket

6000+

Trade
91%
Yes 94¢No 12¢
6¢
$2,264
$4,229
0%
39%
--
1w 1d 16h
Active
polymarket

5800+

100%
3 pts
Yes 100¢No 0¢
--
--
$2,758
N/A
N/A
--
1w 1d 16h
Yes
polymarket

5600+

100%
1 pt
Yes 100¢No 0¢
--
--
$2,499
N/A
N/A
--
1w 1d 16h
Yes
polymarket

5000+

100%
Yes 100¢No 0¢
--
--
$587
N/A
N/A
--
1w 1d 16h
Yes
polymarket

4600+

100%
Yes 100¢No 0¢
--
--
$338
N/A
N/A
--
1w 1d 16h
Yes
polymarket

4800+

100%
Yes 100¢No 0¢
--
--
$210
N/A
N/A
--
1w 1d 16h
Yes
Total markets: 6

Description

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Polymarket

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Frequently asked questions

On Polymarket, the dashboard for this market tracks the current odds of whether there will be at least a certain number of measles cases reported in the U.S. by the resolution date. You can view the price history, which reflects how traders are assessing the likelihood of different outcomes for the U.S. measles case count. The dashboard also displays the 24-hour trading volume, currently at $961, and the total volume traded to date, which is $10,621. This provides a clear picture of market activity surrounding the U.S. measles case count.

Currently, the prevailing sentiment in this market suggests a very high probability of a significant number of measles cases. This contrasts with some early-year analyst forecasts which predicted a more contained outbreak due to vaccination rates. However, recent reports of localized outbreaks have shifted public health discussions. It's important to note that prediction markets like this one reflect a collective intelligence, incorporating a wider range of information and perspectives than traditional forecasts. The market’s current pricing suggests a different expectation than initial analyses regarding the U.S. measles case count.

On Polymarket, this market is priced through a continuous trading mechanism where participants buy and sell shares representing their belief about the final U.S. measles case count. The price of these shares fluctuates based on supply and demand, effectively creating a probability estimate. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The current top outcome, 'Will there be at least 4600 measles cases in the U.S. by November 30, 2026?', has a chance percentage of 91.0%. This reflects the aggregated views of traders on Polymarket regarding the potential scale of the measles outbreak.

This market resolves around Dec 1, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. The final U.S. measles case count will be determined by data reported by official public health organizations, such as the Centers for Disease Control and Prevention (CDC). The resolution will be based on the total number of confirmed measles cases reported within the United States by that date, providing a definitive answer to the question posed by this market.

Several factors could significantly impact this market. A substantial increase in measles outbreaks in highly populated areas would likely drive up the price of shares representing a higher case count. Conversely, a successful nationwide vaccination campaign or the rapid containment of existing outbreaks could lower those prices. Public health announcements from organizations like the CDC, changes in vaccination policies, and even media coverage influencing public perception could all move this market. Monitoring these signals will be crucial for understanding the evolving expectations surrounding the U.S. measles case count.